The possibility of predicting the response of patients with early breast cancer to subsequent endocrine ablation.
D015065:17-Hydroxycorticosteroids; D000315:Adrenalectomy; D000738:Androsterone; D001943:Breast Neoplasms / Q000601:surgery*; D003687:Dehydroepiandrosterone; D005043:Etiocholanolone; D005260:Female; D006801:Humans; D007016:Hypophysectomy; D008408:Mastectomy; D014556:Urine
D015065:17-Hydroxycorticosteroids; D003687:Dehydroepiandrosterone; D005043:Etiocholanolone; D000738:Androsterone